BIO-TECHNE Corp Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q2 2010 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
BIO-TECHNE Corp quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q2 2010 to Q2 2024.
- BIO-TECHNE Corp Deferred Tax Assets, Net of Valuation Allowance for the quarter ending June 30, 2024 was $109M, a 15% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)